Chinese General Practice ›› 2023, Vol. 26 ›› Issue (14): 1716-1725.DOI: 10.12114/j.issn.1007-9572.2022.0755
• Original Research • Previous Articles Next Articles
Received:
2022-06-20
Revised:
2022-12-12
Published:
2023-05-15
Online:
2023-01-05
Contact:
HONG Xin
通讯作者:
洪忻
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0755
组别 | 例数 | 年龄(岁) | 受教育程度〔n(%)〕 | 职业〔n(%)〕 | 吸烟〔n(%)〕 | |||||
---|---|---|---|---|---|---|---|---|---|---|
小学及以下 | 初中及高中 | 大学及以上 | 体力劳动者 | 非体力劳动者 | 未就业/离退休 | 学生 | ||||
MHNW表型 | 23 691 | 37.9±14.5 | 1 215(5.13) | 8 769(37.09) | 13 707(57.78) | 5 939(25.07) | 12 023(50.75) | 3 443(14.53) | 2 286(9.65) | 3 764(15.89) |
MONW表型 | 6 717 | 50.9±16.3 | 784(11.67) | 3 538(52.67) | 2 395(35.66) | 1 745(25.98) | 2 402(35.76) | 2 389(35.57) | 181(2.69) | 1 532(22.81) |
检验统计量值 | -63.19a | 1 144.99b | 1 768.72b | 174.23b | ||||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||
组别 | 饮酒〔n(%)〕 | 体力活动〔M(P25,P75),MET-h/d〕 | 静态行为时间〔M(P25,P75),h〕 | 高红肉摄入〔n(%)〕 | 低水果蔬菜摄入〔n(%)〕 | 疾病史〔n(%)〕 | ||||
高血压 | 糖尿病 | 血脂异常 | ||||||||
MHNW表型 | 6 027(25.44) | 2.95(1.14,6.00) | 4.50(3.00,7.00) | 10 564(44.59) | 7 476(31.56) | 2 023(8.54) | 452(1.91) | 2 997(12.65) | ||
MONW表型 | 1 855(27.62) | 3.43(1.33,6.67) | 4.00(3.00,6.00) | 2 851(42.44) | 2 134(31.77) | 2 838(42.25) | 1 362(20.28) | 2 930(43.62) | ||
检验统计量值 | 12.91b | -6.74 | -7.50 | 15.36b | 0.43b | 4 428.41b | 3 147.79b | 3 198.70b | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.806 | <0.001 | <0.001 | <0.001 | ||
组别 | 用药史〔n(%)〕c | 身高(cm) | WC(cm) | BMI(kg/m2) | TC(mmol/L) | TG〔M(P25,P75),mmol/L〕 | HDL-C(mmol/L) | |||
高血压用药 | 糖尿病用药 | |||||||||
MHNW表型 | 913(3.85) | 171(0.72) | 166.2±7.9 | 76.8±7.3 | 21.6±1.5 | 4.43±0.98 | 1.10(0.80,1.40) | 1.54±0.50 | ||
MONW表型 | 1 771(26.37) | 854(12.71) | 165.2±8.1 | 79.6±7.5 | 22.1±1.4 | 4.74±1.15 | 1.70(1.20,2.19) | 1.37±0.54 | ||
检验统计量值 | 3 295.66b | 2 310.60b | 9.63a | -27.53a | -25.96a | -21.86a | -65.33 | 24.56a | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||
组别 | LDL-C(mmol/L) | SBP(mm Hg) | DBP(mm Hg) | FPG(mmol/L) | TG/HDL-C〔M(P25,P75)〕 | WHtR〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | |||
MHNW表型 | 2.49±0.78 | 112±16 | 74±12 | 4.88±0.86 | 0.75(0.51,1.00) | 0.46(0.43,0.49) | 0.35(0.23,0.47) | |||
MONW表型 | 2.76±0.87 | 129±24 | 80±17 | 5.92±1.88 | 1.27(0.89,1.80) | 0.48(0.45,0.51) | 0.61(0.43,0.87) | |||
检验统计量值 | -24.80a | -45.64a | -29.92a | -64.51a | -69.63 | -33.70 | -72.82 | |||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of basic data of the subjects
组别 | 例数 | 年龄(岁) | 受教育程度〔n(%)〕 | 职业〔n(%)〕 | 吸烟〔n(%)〕 | |||||
---|---|---|---|---|---|---|---|---|---|---|
小学及以下 | 初中及高中 | 大学及以上 | 体力劳动者 | 非体力劳动者 | 未就业/离退休 | 学生 | ||||
MHNW表型 | 23 691 | 37.9±14.5 | 1 215(5.13) | 8 769(37.09) | 13 707(57.78) | 5 939(25.07) | 12 023(50.75) | 3 443(14.53) | 2 286(9.65) | 3 764(15.89) |
MONW表型 | 6 717 | 50.9±16.3 | 784(11.67) | 3 538(52.67) | 2 395(35.66) | 1 745(25.98) | 2 402(35.76) | 2 389(35.57) | 181(2.69) | 1 532(22.81) |
检验统计量值 | -63.19a | 1 144.99b | 1 768.72b | 174.23b | ||||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||
组别 | 饮酒〔n(%)〕 | 体力活动〔M(P25,P75),MET-h/d〕 | 静态行为时间〔M(P25,P75),h〕 | 高红肉摄入〔n(%)〕 | 低水果蔬菜摄入〔n(%)〕 | 疾病史〔n(%)〕 | ||||
高血压 | 糖尿病 | 血脂异常 | ||||||||
MHNW表型 | 6 027(25.44) | 2.95(1.14,6.00) | 4.50(3.00,7.00) | 10 564(44.59) | 7 476(31.56) | 2 023(8.54) | 452(1.91) | 2 997(12.65) | ||
MONW表型 | 1 855(27.62) | 3.43(1.33,6.67) | 4.00(3.00,6.00) | 2 851(42.44) | 2 134(31.77) | 2 838(42.25) | 1 362(20.28) | 2 930(43.62) | ||
检验统计量值 | 12.91b | -6.74 | -7.50 | 15.36b | 0.43b | 4 428.41b | 3 147.79b | 3 198.70b | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.806 | <0.001 | <0.001 | <0.001 | ||
组别 | 用药史〔n(%)〕c | 身高(cm) | WC(cm) | BMI(kg/m2) | TC(mmol/L) | TG〔M(P25,P75),mmol/L〕 | HDL-C(mmol/L) | |||
高血压用药 | 糖尿病用药 | |||||||||
MHNW表型 | 913(3.85) | 171(0.72) | 166.2±7.9 | 76.8±7.3 | 21.6±1.5 | 4.43±0.98 | 1.10(0.80,1.40) | 1.54±0.50 | ||
MONW表型 | 1 771(26.37) | 854(12.71) | 165.2±8.1 | 79.6±7.5 | 22.1±1.4 | 4.74±1.15 | 1.70(1.20,2.19) | 1.37±0.54 | ||
检验统计量值 | 3 295.66b | 2 310.60b | 9.63a | -27.53a | -25.96a | -21.86a | -65.33 | 24.56a | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||
组别 | LDL-C(mmol/L) | SBP(mm Hg) | DBP(mm Hg) | FPG(mmol/L) | TG/HDL-C〔M(P25,P75)〕 | WHtR〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | |||
MHNW表型 | 2.49±0.78 | 112±16 | 74±12 | 4.88±0.86 | 0.75(0.51,1.00) | 0.46(0.43,0.49) | 0.35(0.23,0.47) | |||
MONW表型 | 2.76±0.87 | 129±24 | 80±17 | 5.92±1.88 | 1.27(0.89,1.80) | 0.48(0.45,0.51) | 0.61(0.43,0.87) | |||
检验统计量值 | -24.80a | -45.64a | -29.92a | -64.51a | -69.63 | -33.70 | -72.82 | |||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | 年龄(岁) | 受教育程度〔n(%)〕 | 职业〔n(%)〕 | 吸烟〔n(%)〕 | |||||
---|---|---|---|---|---|---|---|---|---|---|
小学及以下 | 初中及高中 | 大学及以上 | 体力劳动者 | 非体力劳动者 | 未就业/离退休 | 学生 | ||||
MHNW表型 | 10 129 | 37.8±15.5 | 430(4.25) | 3 823(37.74) | 5 876(58.01) | 2 707(26.73) | 4 996(49.32) | 1 124(11.10) | 1 302(12.85) | 3 619(35.73) |
MONW表型 | 3 084 | 51.1±16.5 | 258(8.37) | 1 651(53.53) | 1 175(38.10) | 862(27.95) | 1 200(38.91) | 924(29.96) | 98(3.18) | 1 466(47.54) |
检验统计量值 | -41.46a | 395.04b | 807.70b | 139.21b | ||||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||
组别 | 饮酒〔n(%)〕 | 体力活动〔M(P25,P75),MET-h/d〕 | 静态行为时间〔M(P25,P75),h〕 | 高红肉摄入〔n(%)〕 | 低水果蔬菜摄入〔n(%)〕 | 疾病史〔n(%)〕 | ||||
高血压 | 糖尿病 | 血脂异常 | ||||||||
MHNW表型 | 4 381(43.25) | 3.05(1.14,6.00) | 5.00(3.00,7.00) | 5 105(50.40) | 5 822(57.48) | 1 059(10.46) | 206(2.03) | 1 258(12.42) | ||
MONW表型 | 1 489(48.28) | 3.24(1.24,6.00) | 4.50(3.00,6.00) | 1 453(47.11) | 1 784(57.85) | 1 410(45.72) | 713(23.12) | 1 437(46.60) | ||
检验统计量值 | 24.22b | -1.64 | -5.51 | 19.41b | 2.65b | 1 934.98b | 1 624.22b | 1 700.68b | ||
P值 | <0.001 | 0.102 | <0.001 | <0.001 | 0.266 | <0.001 | <0.001 | <0.001 | ||
组别 | 用药史〔n(%)〕c | 身高(cm) | WC(cm) | BMI(kg/m2) | TC(mmol/L) | TG〔M(P25,P75),mmol/L〕 | HDL-C(mmol/L) | |||
高血压用药 | 糖尿病用药 | |||||||||
MHNW表型 | 492(4.86) | 90(0.89) | 172.8±5.8 | 79.9±7.1 | 21.9±1.4 | 4.36±0.94 | 1.14(0.86,1.44) | 1.48±0.47 | ||
MONW表型 | 869(28.18) | 447(14.49) | 171.3±6.0 | 82.4±7.1 | 22.3±1.3 | 4.68±1.13 | 1.72(1.20,2.20) | 1.36±0.57 | ||
检验统计量值 | 1 391.56b | 1 122.44b | 12.39a | -16.73a | -15.07a | -15.63a | -42.39 | 11.30a | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||
组别 | LDL-C(mmol/L) | SBP(mm Hg) | DBP(mm Hg) | FPG(mmol/L) | TG/HDL-C〔M(P25,P75)〕 | WHtR〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | |||
MHNW表型 | 2.48±0.78 | 120±16 | 76±14 | 4.91±0.99 | 0.82(0.57,1.07) | 0.46(0.44,0.49) | 0.37(0.26,0.49) | |||
MONW表型 | 2.72±0.85 | 131±21 | 81±12 | 6.07±2.10 | 1.31(0.89,1.89) | 0.48(0.45,0.51) | 0.63(0.43,0.91) | |||
检验统计量值 | -15.07a | -29.64a | -17.97a | -41.87a | -21.92 | -43.00 | -45.04 | |||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 2 Basic data comparison of male subjects
组别 | 例数 | 年龄(岁) | 受教育程度〔n(%)〕 | 职业〔n(%)〕 | 吸烟〔n(%)〕 | |||||
---|---|---|---|---|---|---|---|---|---|---|
小学及以下 | 初中及高中 | 大学及以上 | 体力劳动者 | 非体力劳动者 | 未就业/离退休 | 学生 | ||||
MHNW表型 | 10 129 | 37.8±15.5 | 430(4.25) | 3 823(37.74) | 5 876(58.01) | 2 707(26.73) | 4 996(49.32) | 1 124(11.10) | 1 302(12.85) | 3 619(35.73) |
MONW表型 | 3 084 | 51.1±16.5 | 258(8.37) | 1 651(53.53) | 1 175(38.10) | 862(27.95) | 1 200(38.91) | 924(29.96) | 98(3.18) | 1 466(47.54) |
检验统计量值 | -41.46a | 395.04b | 807.70b | 139.21b | ||||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||
组别 | 饮酒〔n(%)〕 | 体力活动〔M(P25,P75),MET-h/d〕 | 静态行为时间〔M(P25,P75),h〕 | 高红肉摄入〔n(%)〕 | 低水果蔬菜摄入〔n(%)〕 | 疾病史〔n(%)〕 | ||||
高血压 | 糖尿病 | 血脂异常 | ||||||||
MHNW表型 | 4 381(43.25) | 3.05(1.14,6.00) | 5.00(3.00,7.00) | 5 105(50.40) | 5 822(57.48) | 1 059(10.46) | 206(2.03) | 1 258(12.42) | ||
MONW表型 | 1 489(48.28) | 3.24(1.24,6.00) | 4.50(3.00,6.00) | 1 453(47.11) | 1 784(57.85) | 1 410(45.72) | 713(23.12) | 1 437(46.60) | ||
检验统计量值 | 24.22b | -1.64 | -5.51 | 19.41b | 2.65b | 1 934.98b | 1 624.22b | 1 700.68b | ||
P值 | <0.001 | 0.102 | <0.001 | <0.001 | 0.266 | <0.001 | <0.001 | <0.001 | ||
组别 | 用药史〔n(%)〕c | 身高(cm) | WC(cm) | BMI(kg/m2) | TC(mmol/L) | TG〔M(P25,P75),mmol/L〕 | HDL-C(mmol/L) | |||
高血压用药 | 糖尿病用药 | |||||||||
MHNW表型 | 492(4.86) | 90(0.89) | 172.8±5.8 | 79.9±7.1 | 21.9±1.4 | 4.36±0.94 | 1.14(0.86,1.44) | 1.48±0.47 | ||
MONW表型 | 869(28.18) | 447(14.49) | 171.3±6.0 | 82.4±7.1 | 22.3±1.3 | 4.68±1.13 | 1.72(1.20,2.20) | 1.36±0.57 | ||
检验统计量值 | 1 391.56b | 1 122.44b | 12.39a | -16.73a | -15.07a | -15.63a | -42.39 | 11.30a | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||
组别 | LDL-C(mmol/L) | SBP(mm Hg) | DBP(mm Hg) | FPG(mmol/L) | TG/HDL-C〔M(P25,P75)〕 | WHtR〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | |||
MHNW表型 | 2.48±0.78 | 120±16 | 76±14 | 4.91±0.99 | 0.82(0.57,1.07) | 0.46(0.44,0.49) | 0.37(0.26,0.49) | |||
MONW表型 | 2.72±0.85 | 131±21 | 81±12 | 6.07±2.10 | 1.31(0.89,1.89) | 0.48(0.45,0.51) | 0.63(0.43,0.91) | |||
检验统计量值 | -15.07a | -29.64a | -17.97a | -41.87a | -21.92 | -43.00 | -45.04 | |||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | 年龄(岁) | 受教育程度〔n(%)〕 | 职业〔n(%)〕 | 吸烟〔n(%)〕 | |||||
---|---|---|---|---|---|---|---|---|---|---|
小学及以下 | 初中及高中 | 大学及以上 | 体力劳动者 | 非体力劳动者 | 未就业/离退休 | 学生 | ||||
MHNW表型 | 13 562 | 38.0±13.6 | 785(5.79) | 4 946(36.47) | 7 831(57.74) | 3 232(23.83) | 7 027(51.81) | 2 319(17.10) | 984(7.26) | 145(1.07) |
MONW表型 | 3 633 | 50.7±16.0 | 526(14.48) | 1 887(51.94) | 1 220(33.58) | 883(24.30) | 1 202(33.09) | 1 465(40.32) | 83(2.28) | 66(1.82) |
检验统计量值 | -47.77a | 774.19b | 1 026.76b | 13.21b | ||||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||
组别 | 饮酒〔n(%)〕 | 体力活动〔M(P25,P75),MET-h/d〕 | 静态行为时间〔M(P25,P75),h〕 | 高红肉摄入〔n(%)〕 | 低水果蔬菜摄入〔n(%)〕 | 疾病史〔n(%)〕 | ||||
高血压 | 糖尿病 | 血脂异常 | ||||||||
MHNW表型 | 1 646(12.14) | 2.86(1.14,6.00) | 4.50(3.00,6.50) | 5 459(40.25) | 7 265(53.57) | 964(7.11) | 246(1.81) | 1 739(12.82) | ||
MONW表型 | 366(10.07) | 3.71(1.43,7.00) | 4.00(2.50,6.00) | 1 398(38.48) | 1 932(53.18) | 1 428(39.31) | 649(17.86) | 1 493(41.10) | ||
检验统计量值 | 11.80b | -7.69 | -5.48 | 4.27b | 0.41b | 2 480.53b | 1 496.02b | 1 500.66b | ||
P值 | <0.001 | <0.001 | <0.001 | 0.118 | 0.815 | <0.001 | <0.001 | <0.001 | ||
组别 | 用药史〔n(%)〕c | 身高(cm) | WC(cm) | BMI(kg/m2) | TC(mmol/L) | TG〔M(P25,P75),mmol/L〕 | HDL-C(mmol/L) | |||
高血压用药 | 糖尿病用药 | |||||||||
MHNW表型 | 421(3.10) | 81(0.60) | 161.3±5.0 | 74.5±6.5 | 21.3±1.5 | 4.48±1.01 | 1.07(1.20,2.14) | 1.60±0.51 | ||
MONW表型 | 902(24.83) | 407(11.20) | 156.0±5.5 | 77.2±7.1 | 21.9±1.4 | 4.97±1.17 | 1.70(1.20,2.14) | 1.38±0.52 | ||
检验统计量值 | 1 904.00b | 1 168.81b | 13.99a | -22.38a | -20.77a | -15.80a | -49.69 | 22.35a | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||
组别 | LDL-C(mmol/L) | SBP(mm Hg) | DBP(mm Hg) | FPG(mmol/L) | TG/HDL-C〔M(P25,P75)〕 | WHtR〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | |||
MHNW表型 | 2.49±0.79 | 116±16 | 73±10 | 4.85±1.01 | 0.70(0.48,0.95) | 0.46(0.43,0.49) | 0.32(0.22,0.44) | |||
MONW表型 | 2.79±0.88 | 128±26 | 79±20 | 5.79±1.67 | 1.22(0.88,1.73) | 0.48(0.45,0.51) | 0.59(0.42,0.84) | |||
检验统计量值 | -19.90a | -34.50a | -23.73a | -49.81a | -25.55 | -54.91 | -57.35 | |||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 3 Basic data comparison of female subjects
组别 | 例数 | 年龄(岁) | 受教育程度〔n(%)〕 | 职业〔n(%)〕 | 吸烟〔n(%)〕 | |||||
---|---|---|---|---|---|---|---|---|---|---|
小学及以下 | 初中及高中 | 大学及以上 | 体力劳动者 | 非体力劳动者 | 未就业/离退休 | 学生 | ||||
MHNW表型 | 13 562 | 38.0±13.6 | 785(5.79) | 4 946(36.47) | 7 831(57.74) | 3 232(23.83) | 7 027(51.81) | 2 319(17.10) | 984(7.26) | 145(1.07) |
MONW表型 | 3 633 | 50.7±16.0 | 526(14.48) | 1 887(51.94) | 1 220(33.58) | 883(24.30) | 1 202(33.09) | 1 465(40.32) | 83(2.28) | 66(1.82) |
检验统计量值 | -47.77a | 774.19b | 1 026.76b | 13.21b | ||||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||
组别 | 饮酒〔n(%)〕 | 体力活动〔M(P25,P75),MET-h/d〕 | 静态行为时间〔M(P25,P75),h〕 | 高红肉摄入〔n(%)〕 | 低水果蔬菜摄入〔n(%)〕 | 疾病史〔n(%)〕 | ||||
高血压 | 糖尿病 | 血脂异常 | ||||||||
MHNW表型 | 1 646(12.14) | 2.86(1.14,6.00) | 4.50(3.00,6.50) | 5 459(40.25) | 7 265(53.57) | 964(7.11) | 246(1.81) | 1 739(12.82) | ||
MONW表型 | 366(10.07) | 3.71(1.43,7.00) | 4.00(2.50,6.00) | 1 398(38.48) | 1 932(53.18) | 1 428(39.31) | 649(17.86) | 1 493(41.10) | ||
检验统计量值 | 11.80b | -7.69 | -5.48 | 4.27b | 0.41b | 2 480.53b | 1 496.02b | 1 500.66b | ||
P值 | <0.001 | <0.001 | <0.001 | 0.118 | 0.815 | <0.001 | <0.001 | <0.001 | ||
组别 | 用药史〔n(%)〕c | 身高(cm) | WC(cm) | BMI(kg/m2) | TC(mmol/L) | TG〔M(P25,P75),mmol/L〕 | HDL-C(mmol/L) | |||
高血压用药 | 糖尿病用药 | |||||||||
MHNW表型 | 421(3.10) | 81(0.60) | 161.3±5.0 | 74.5±6.5 | 21.3±1.5 | 4.48±1.01 | 1.07(1.20,2.14) | 1.60±0.51 | ||
MONW表型 | 902(24.83) | 407(11.20) | 156.0±5.5 | 77.2±7.1 | 21.9±1.4 | 4.97±1.17 | 1.70(1.20,2.14) | 1.38±0.52 | ||
检验统计量值 | 1 904.00b | 1 168.81b | 13.99a | -22.38a | -20.77a | -15.80a | -49.69 | 22.35a | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||
组别 | LDL-C(mmol/L) | SBP(mm Hg) | DBP(mm Hg) | FPG(mmol/L) | TG/HDL-C〔M(P25,P75)〕 | WHtR〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | |||
MHNW表型 | 2.49±0.79 | 116±16 | 73±10 | 4.85±1.01 | 0.70(0.48,0.95) | 0.46(0.43,0.49) | 0.32(0.22,0.44) | |||
MONW表型 | 2.79±0.88 | 128±26 | 79±20 | 5.79±1.67 | 1.22(0.88,1.73) | 0.48(0.45,0.51) | 0.59(0.42,0.84) | |||
检验统计量值 | -19.90a | -34.50a | -23.73a | -49.81a | -25.55 | -54.91 | -57.35 | |||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
自变量 | b | SE | Wald χ2值 | P值 | RR(95%CI) |
---|---|---|---|---|---|
模型1 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.43 | 0.08 | 8.60 | <0.001 | 1.54(1.39,1.70) |
Q3组 | 0.88 | 0.12 | 20.34 | <0.001 | 2.42(2.20,2.65) |
Q4组 | 1.86 | 0.28 | 45.11 | <0.001 | 6.44(5.92,7.00) |
模型2 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.43 | 0.08 | 8.33 | <0.001 | 1.53(1.39,1.70) |
Q3组 | 0.88 | 0.11 | 18.60 | <0.001 | 2.40(2.19,2.64) |
Q4组 | 1.85 | 0.27 | 42.89 | <0.001 | 6.36(5.84,6.92) |
模型3 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.39 | 0.08 | 8.33 | <0.001 | 1.48(1.35,1.63) |
Q3组 | 0.83 | 0.11 | 18.60 | <0.001 | 2.29(2.10,2.51) |
Q4组 | 1.63 | 0.28 | 42.89 | <0.001 | 5.09(4.68,5.53) |
Table 4 Multivariate Robust Poisson regression models with different CMI groups
自变量 | b | SE | Wald χ2值 | P值 | RR(95%CI) |
---|---|---|---|---|---|
模型1 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.43 | 0.08 | 8.60 | <0.001 | 1.54(1.39,1.70) |
Q3组 | 0.88 | 0.12 | 20.34 | <0.001 | 2.42(2.20,2.65) |
Q4组 | 1.86 | 0.28 | 45.11 | <0.001 | 6.44(5.92,7.00) |
模型2 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.43 | 0.08 | 8.33 | <0.001 | 1.53(1.39,1.70) |
Q3组 | 0.88 | 0.11 | 18.60 | <0.001 | 2.40(2.19,2.64) |
Q4组 | 1.85 | 0.27 | 42.89 | <0.001 | 6.36(5.84,6.92) |
模型3 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.39 | 0.08 | 8.33 | <0.001 | 1.48(1.35,1.63) |
Q3组 | 0.83 | 0.11 | 18.60 | <0.001 | 2.29(2.10,2.51) |
Q4组 | 1.63 | 0.28 | 42.89 | <0.001 | 5.09(4.68,5.53) |
自变量 | b | SE | Wald χ2值 | P值 | RR(95%CI) |
---|---|---|---|---|---|
模型1 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.22 | 0.09 | 3.04 | 0.002 | 1.24(1.08,1.43) |
Q3组 | 0.58 | 0.12 | 8.78 | <0.001 | 1.78(1.57,2.03) |
Q4组 | 1.62 | 0.29 | 27.55 | <0.001 | 5.03(4.48,5.64) |
模型2 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.22 | 0.09 | 3.03 | 0.002 | 1.24(1.08,1.43) |
Q3组 | 0.57 | 0.12 | 8.68 | <0.001 | 1.77(1.56,2.02) |
Q4组 | 1.60 | 0.29 | 27.32 | <0.001 | 4.97(4.43,5.58) |
模型3 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.17 | 0.08 | 2.70 | 0.007 | 1.19(1.05,1.36) |
Q3组 | 0.53 | 0.10 | 8.53 | <0.001 | 1.69(1.50,1.90) |
Q4组 | 1.32 | 0.21 | 22.64 | <0.001 | 3.76(3.28,4.10) |
Table 5 Multivariate Robust Poisson regression model of male subjects in different CMI groups
自变量 | b | SE | Wald χ2值 | P值 | RR(95%CI) |
---|---|---|---|---|---|
模型1 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.22 | 0.09 | 3.04 | 0.002 | 1.24(1.08,1.43) |
Q3组 | 0.58 | 0.12 | 8.78 | <0.001 | 1.78(1.57,2.03) |
Q4组 | 1.62 | 0.29 | 27.55 | <0.001 | 5.03(4.48,5.64) |
模型2 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.22 | 0.09 | 3.03 | 0.002 | 1.24(1.08,1.43) |
Q3组 | 0.57 | 0.12 | 8.68 | <0.001 | 1.77(1.56,2.02) |
Q4组 | 1.60 | 0.29 | 27.32 | <0.001 | 4.97(4.43,5.58) |
模型3 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.17 | 0.08 | 2.70 | 0.007 | 1.19(1.05,1.36) |
Q3组 | 0.53 | 0.10 | 8.53 | <0.001 | 1.69(1.50,1.90) |
Q4组 | 1.32 | 0.21 | 22.64 | <0.001 | 3.76(3.28,4.10) |
自变量 | b | SE | Wald χ2值 | P值 | RR(95%CI) |
---|---|---|---|---|---|
模型1 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.58 | 0.12 | 8.37 | <0.001 | 1.79(1.56,2.05) |
Q3组 | 1.19 | 0.21 | 18.78 | <0.001 | 3.28(2.90,3.72) |
Q4组 | 2.10 | 0.49 | 35.35 | <0.001 | 8.20(7.30,9.21) |
模型2 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.58 | 0.12 | 8.35 | <0.001 | 1.79(1.56,2.05) |
Q3组 | 1.19 | 0.21 | 18.74 | <0.001 | 3.28(2.90,3.71) |
Q4组 | 2.10 | 0.48 | 35.18 | <0.001 | 8.13(7.24,9.14) |
模型3 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.55 | 0.12 | 8.23 | <0.001 | 1.74(1.52,1.98) |
Q3组 | 1.15 | 0.19 | 18.81 | <0.001 | 3.16(2.81,3.57) |
Q4组 | 1.94 | 0.42 | 32.34 | <0.001 | 6.94(6.17,7.80) |
Table 6 Multivariate Robust Poisson regression model of female subjects in different CMI groups
自变量 | b | SE | Wald χ2值 | P值 | RR(95%CI) |
---|---|---|---|---|---|
模型1 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.58 | 0.12 | 8.37 | <0.001 | 1.79(1.56,2.05) |
Q3组 | 1.19 | 0.21 | 18.78 | <0.001 | 3.28(2.90,3.72) |
Q4组 | 2.10 | 0.49 | 35.35 | <0.001 | 8.20(7.30,9.21) |
模型2 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.58 | 0.12 | 8.35 | <0.001 | 1.79(1.56,2.05) |
Q3组 | 1.19 | 0.21 | 18.74 | <0.001 | 3.28(2.90,3.71) |
Q4组 | 2.10 | 0.48 | 35.18 | <0.001 | 8.13(7.24,9.14) |
模型3 | |||||
CMI分组(以Q1组为参照) | |||||
Q2组 | 0.55 | 0.12 | 8.23 | <0.001 | 1.74(1.52,1.98) |
Q3组 | 1.15 | 0.19 | 18.81 | <0.001 | 3.16(2.81,3.57) |
Q4组 | 1.94 | 0.42 | 32.34 | <0.001 | 6.94(6.17,7.80) |
项目 | 最佳截断值 | AUC(95%CI) | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|
CMI | 0.55 | 0.767(0.757,0.778) | 82.9 | 60.3 |
WHtR | 0.47 | 0.630(0.619,0.641) | 56.1 | 65.0 |
TG/HDL-C | 1.09 | 0.755(0.745,0.766) | 78.2 | 63.9 |
WC | 80.75 cm | 0.601(0.590,0.612) | 58.8 | 56.3 |
BMI | 22.02 kg/m2 | 0.588(0.577,0.599) | 45.6 | 65.6 |
Table 7 Comparison of the predictive value of different indicators for MONW phenotype in male subjects
项目 | 最佳截断值 | AUC(95%CI) | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|
CMI | 0.55 | 0.767(0.757,0.778) | 82.9 | 60.3 |
WHtR | 0.47 | 0.630(0.619,0.641) | 56.1 | 65.0 |
TG/HDL-C | 1.09 | 0.755(0.745,0.766) | 78.2 | 63.9 |
WC | 80.75 cm | 0.601(0.590,0.612) | 58.8 | 56.3 |
BMI | 22.02 kg/m2 | 0.588(0.577,0.599) | 45.6 | 65.6 |
项目 | 最佳截断值 | AUC(95%CI) | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|
CMI | 0.49 | 0.809(0.801,0.818) | 81.6 | 66.1 |
WHtR | 0.48 | 0.638(0.628,0.648) | 67.6 | 52.6 |
TG/HDL-C | 0.94 | 0.796(0.787,0.805) | 74.8 | 70.6 |
WC | 75.25 cm | 0.616(0.606,0.626) | 57.5 | 59.5 |
BMI | 21.32 kg/m2 | 0.611(0.601,0.621) | 49.2 | 68.3 |
Table 8 Comparison of the predictive value of different indicators for MONW phenotype in female subjects
项目 | 最佳截断值 | AUC(95%CI) | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|
CMI | 0.49 | 0.809(0.801,0.818) | 81.6 | 66.1 |
WHtR | 0.48 | 0.638(0.628,0.648) | 67.6 | 52.6 |
TG/HDL-C | 0.94 | 0.796(0.787,0.805) | 74.8 | 70.6 |
WC | 75.25 cm | 0.616(0.606,0.626) | 57.5 | 59.5 |
BMI | 21.32 kg/m2 | 0.611(0.601,0.621) | 49.2 | 68.3 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
中华人民共和国卫生部疾病控制司. 中国成人超重和肥胖症预防控制指南[M]. 北京:人民卫生出版社,2006.
|
[11] |
|
[12] |
中国预防医学科学院. 1996年全国吸烟行为的流行病学调查:中国吸烟与健康研究[M]. 北京:中国科学技术出版社,1997:155-158.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
中国高血压防治指南修订委员会,高血压联盟(中国,中华医学会心血管病学分会中国医师协会高血压专业委员会,等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志,2019,24(1):24-56. DOI:10.3969/j.issn.1007-5410.2019.01.002.
|
[17] |
中华医学会糖尿病分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.DOI:10.3760/cma.j.issn.1674-5809.2018.01.003.
|
[18] |
中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志,2016,31(10):937-950. DOI:10.3969/j.issn.1000-3614.2016.10.001.
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[1] | LIANG Xiaoxian, YANG Jin, JIN Juzhen, ZHOU Jing, HU Jin, GAI Yun, DING Xiaoyun, WANG Junhua, WANG Ziyun. Association between Chronotype and Dyslipidemia among Population Aged 40-65 Years [J]. Chinese General Practice, 2023, 26(34): 4277-4282. |
[2] | WANG Qiushi, LI Hongwei. The Predictive Value of CHA2DS2-VASc Score on Major Adverse Cardiovascular Events in Patients with Three Vessels or Left Main Diseases of Coronary Heart Disease [J]. Chinese General Practice, 2023, 26(33): 4130-4136. |
[3] | HE Yingmei, JIA Xue, ZHU Guojun, LIU Bing. Effect of Serum Uric Acid Longitudinal Trajectory on New-onset Hypertriglyceridemia: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(29): 3636-3639. |
[4] | HUANG Qixian, WEN Yanting, HUANG Jun, LI Weibin, XU Yongneng, LIN Xiayi, WANG Haoxiang, WENG Fan, YANG Lianping. Prevalence of Dyslipidemia and Its Influencing Factors among Elderly Community Residents [J]. Chinese General Practice, 2023, 26(28): 3520-3525. |
[5] | BIAN Lili, LI Xiaoxiao, DU Xueping, DAI Qinfang, WU Lin, SONG Beibei. Risk Stratification of Atherosclerotic Cardiovascular Disease and Lipid Goal Attainment in Hypertensive Patients Registered in Community [J]. Chinese General Practice, 2023, 26(27): 3388-3391. |
[6] | ZHOU Shiyu, CHEN Shaolin, DENG Renli, DAI Mi, LIU Tao, TIAN Kunming. The Association and Predictive Value of Lipid Ratios to Metabolic Syndrome: a Multistage Cross-sectional Study [J]. Chinese General Practice, 2023, 26(21): 2589-2596. |
[7] | JIANG Qixia, ZHOU Jihong, CHEN Kesu, HONG Yanyan, PENG Qing, ZHAN Yingying, XIE Yijie, SUN Ying, WANG Zujing. Pressure Injuries among Adult Inpatients in 46 Tertiary Hospitals in China: Epidemiological Characteristics and Predictive Value of the Braden Scale [J]. Chinese General Practice, 2023, 26(18): 2195-2202. |
[8] | CHEN Ying, WANG Zihan, XUE Chongxiang, TAO Shiyi, SUN Ziyi, HUANG Li. The Predictive Value of Ankle Brachial Index, Brachial-ankle Pulse Wave Velocity, Flow-mediated Dilation Combined with Apolipoprotein B to Apolipoprotein A-1 Ration on Coronary Heart Disease with Blood Stasis Syndrome in Middle-aged and Young Adults [J]. Chinese General Practice, 2023, 26(14): 1726-1732. |
[9] | YANG Yi, CONG Huiwen, WANG Lianyuan, YANG Liping, BAO Qihan, WANG Haohua, LI Chengsheng, ZHOU Liwen, DING Zichen, SHI Fuyan, WANG Suzhen. Longitudinal Study on the Risk Factors of Stroke in Check-up Population Based on Bayesian Multivariate Joint Model [J]. Chinese General Practice, 2023, 26(12): 1437-1443. |
[10] | LIU Chuanfen, LI Zheng, WU Manyan, CUI Yuxia, SONG Jing, ZHANG Chunying, CHEN Hong. Analysis of Serum Lipid Level and Drug Use in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(11): 1325-1329. |
[11] | WANG Hongxin, FAN Wenlong, YANG Xiaoyu, CHEN Dongyu, HUANG Qiao, PAN Suyue, WANG Pu, HU Min, HE Yuqing. Protein-energy Malnutrition Incidence in China: Trend in 1990-2019 and Future Trend in 2020-2029 [J]. Chinese General Practice, 2023, 26(05): 591-597. |
[12] | Meixin LI, Xin ZHENG, Xiaoying ZHANG, Xiaoxia DU. Effects of Music Therapy Assisted Anagliptin on Glycolipid Metabolism in Patients with Type 2 Diabetes [J]. Chinese General Practice, 2022, 25(26): 3275-3280. |
[13] | Ke QIN, Tonglin LI, Shuai GONG, Meifang JIANG. Changes and Response Predictive Values of Serum miR-210 and miR-181a in Stable Chronic Obstructive Pulmonary Disease Patients Treated with Glucocorticoid Therapy [J]. Chinese General Practice, 2022, 25(24): 3013-3017. |
[14] | Jingjing GUI, Aquan JIN, Yu WAN, Xuan ZHAO, Linjie ZHU, Yidong ZHAO, Jiaqi YAO, Liwen ZHANG, Zhiying HUANG. Value of Thromboelastography for Condition Assessment in Children with Mycoplasma Pneumoniae Pneumonia [J]. Chinese General Practice, 2022, 25(21): 2624-2628. |
[15] | Yan LUO, Bingyi ZHAO, Yanmei SUN, Haishen TIAN, Yali LI, Yanshang ZHANG, Jian GAO, Zhiqiang CUI. Prenatal Diagnosis and Pregnancy Outcome Analysis of High-risk Fetuses Suggested by Noninvasive Prenatal Screening [J]. Chinese General Practice, 2022, 25(20): 2482-2488. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||